TotalMarketCap

Electra Therapeutics

ETRANasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$449.411 M

$7.16 -10.16%

Close of 6 Nov 2026

As of 6 Nov 2026, Electra Therapeutics (ETRA) has a market capitalization of $449.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #65SL ScienceSLBT$504.7M
  2. #66RegenxbioRGNX$487.2M
  3. #67Electra TherapeuticsETRA$449.4M
  4. #68Editas MedicineEDIT$390.9M
  5. #69Tectonic TherapeuticTECX$382.0M

What if Electra Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$449,868.47

Per share 62,831× higher

Bitcoin $1.53T

$24,341.60

Per share 3,400× higher

Apple $5.02T

$79,911.20

Per share 11,161× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Electra Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.